Double liver trouble: does having both hepatitis b and fatty liver speed up disease?
NCT ID NCT02863757
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This study follows 1500 Chinese adults with chronic hepatitis B, nonalcoholic fatty liver disease, or both, to see how having both conditions changes the risk of serious liver problems like cirrhosis, liver failure, and liver cancer. Researchers will track who develops these complications and when. The goal is to understand whether the combination of the two liver diseases leads to faster or more severe disease progression than having either one alone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study clarifies how having both hepatitis B and fatty liver disease affects liver health, it could guide better monitoring and treatment strategies for these patients.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not test any new therapy. The results may show associations but cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanity and Health GI and Liver Centre
RECRUITINGHong Kong, Hong Kong, 00852, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can a new injection tame chronic hepatitis b?
- Could a common b vitamin tame fatty liver?
- Could a daily dose of citrus fiber tame fatty liver inflammation?
- A second punch against hepatitis b: interferon after RNA drugs may clear the virus
- Could common hepatitis b drugs damage kidneys? a study digs into the data